Press releases

7
May 2019
20:30 E.S.T.

Cellectis Reports Financial Results for First Quarter 2019

Read more
17
Apr 2019
20:30 E.S.T.

Cellectis Announces Oral and Poster Presentations of Allogeneic CAR T-Cell Programs at the 2019 ASGCT Annual Meeting

Read more
2
Apr 2019
20:30 E.S.T.

FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients

Read more
11
Mar 2019
20:10 E.S.T.

Cellectis Reports 4th Quarter and Full Year 2018 Financial Results

Read more
7
Mar 2019
21:30 E.S.T.

Cellectis Enters Lease Agreement to Build Manufacturing Facility, Advancing Towards Commercialization of its UCART Portfolio

Read more
25
Feb 2019
22:00 E.S.T.

Cellectis Publishes Novel Methods to Improve the Safety of CAR T-Cell Therapy and Prevent CRS in the Journal of Biological Chemistry

Read more
10
Dec 2018
21:30 E.S.T.

Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing

Read more
13
Nov 2018
21:30 E.S.T.

Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018

Read more
19
Sep 2018
20:30 E.S.T.

CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board

Read more
18
Sep 2018
20:30 E.S.T.

Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US